Effect of Empagliflozin in Preventing Progression of Renal Dysfunction in Diabetic Patients With Compensated Heart Failure ― Reply ―
Open Access
- 10 June 2021
- journal article
- Published by Japanese Circulation Society in Circulation Reports
- Vol. 3 (6), 359
- https://doi.org/10.1253/circrep.cr-21-0048
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?Circulation, 2021
- Empagliflozin Administration Can Decrease the Dose of Loop Diuretics and Prevent the Exacerbation of Renal Tubular Injury in Patients With Compensated Heart Failure Complicated by DiabetesCirculation Reports, 2020
- Dapagliflozin in Patients with Chronic Kidney DiseaseThe New England Journal of Medicine, 2020
- Empagliflozin and Progression of Kidney Disease in Type 2 DiabetesThe New England Journal of Medicine, 2016